|
rs1800795
|
IL6;STEAP1B;IL6-AS1
|
Diabetes Mellitus, Non-Insulin-Dependent
|
|
0.070 |
GeneticVariation |
BEFREE |
Two common polymorphisms in the promoter of the IL-6 encoding gene IL6, -174G>C (rs1800795) and -573G>C (rs1800796), have been investigated for association with type 2 diabetes in numerous studies but with results that have been largely equivocal.
|
17003362 |
2006 |
|
rs1800796
|
IL6;STEAP1B;IL6-AS1
|
Diabetes Mellitus, Non-Insulin-Dependent
|
|
0.040 |
GeneticVariation |
BEFREE |
Two common polymorphisms in the promoter of the IL-6 encoding gene IL6, -174G>C (rs1800795) and -573G>C (rs1800796), have been investigated for association with type 2 diabetes in numerous studies but with results that have been largely equivocal.
|
17003362 |
2006 |
|
rs1800795
|
IL6;STEAP1B;IL6-AS1
|
Diabetes
|
|
0.010 |
GeneticVariation |
BEFREE |
Our meta-analysis of 5383 diabetes case and 12 069 controls indicated a null association between the best-studied 5' promoter polymorphism--174G>C (rs1800795)--and diabetes risk.
|
16644865 |
2006 |
|
rs1800795
|
IL6;STEAP1B;IL6-AS1
|
Diabetes Mellitus
|
|
0.010 |
GeneticVariation |
BEFREE |
Our meta-analysis of 5383 diabetes case and 12 069 controls indicated a null association between the best-studied 5' promoter polymorphism--174G>C (rs1800795)--and diabetes risk.
|
16644865 |
2006 |
|
rs747126003
|
IL6;IL6-AS1
|
Severe Sepsis
|
|
0.010 |
GeneticVariation |
BEFREE |
TNF-alpha 308 G/A, PAI-1 4G/4G, and EPCR mutations influence the risk of severe sepsis in children.
|
16444434 |
2006 |
|
rs747126003
|
IL6;IL6-AS1
|
Sepsis
|
|
0.010 |
GeneticVariation |
BEFREE |
In this study, the relationship between the TNF-alpha 308G/A, the IL-6-174 G/C, the PAI-1, the FVL, the EPCR, and the Cathepsin G (Ars 125 Ser) polymorphisms and the development and outcome of sepsis in pediatric patients was studied.
|
16444434 |
2006 |
|
rs747126003
|
IL6;IL6-AS1
|
Septicemia
|
|
0.010 |
GeneticVariation |
BEFREE |
In this study, the relationship between the TNF-alpha 308G/A, the IL-6-174 G/C, the PAI-1, the FVL, the EPCR, and the Cathepsin G (Ars 125 Ser) polymorphisms and the development and outcome of sepsis in pediatric patients was studied.
|
16444434 |
2006 |
|
rs1800795
|
IL6;STEAP1B;IL6-AS1
|
Malignant neoplasm of breast
|
|
0.060 |
GeneticVariation |
BEFREE |
Among postmenopausal women not recently exposed to hormones, the AG/GG genotypes of rs1800797 (-596A>G) and the GC/CC genotypes of rs1800795 (-174G>C) significantly reduced risk of breast cancer among non-Hispanic white women [odds ratio (OR), 0.69; 95% confidence interval (95% CI), 0.48-1.00 and OR, 0.68; 95% CI, 0.47-0.99, respectively] and Hispanic/Native American women (OR, 0.48; 95% CI, 0.28-0.83 and OR, 0.44; 95% CI, 0.26-0.99, respectively).
|
17416766 |
2007 |
|
rs1800795
|
IL6;STEAP1B;IL6-AS1
|
Breast Carcinoma
|
|
0.060 |
GeneticVariation |
BEFREE |
Among postmenopausal women not recently exposed to hormones, the AG/GG genotypes of rs1800797 (-596A>G) and the GC/CC genotypes of rs1800795 (-174G>C) significantly reduced risk of breast cancer among non-Hispanic white women [odds ratio (OR), 0.69; 95% confidence interval (95% CI), 0.48-1.00 and OR, 0.68; 95% CI, 0.47-0.99, respectively] and Hispanic/Native American women (OR, 0.48; 95% CI, 0.28-0.83 and OR, 0.44; 95% CI, 0.26-0.99, respectively).
|
17416766 |
2007 |
|
rs1800795
|
IL6;STEAP1B;IL6-AS1
|
Primary malignant neoplasm
|
|
0.040 |
GeneticVariation |
BEFREE |
Having a C allele of the rs1800796 IL6 polymorphisms and the GG genotype of the rs1800795 IL6 polymorphisms was associated with a statistically significantly reduced the risk of colon (OR 0.76 95% CI 0.57, 1.00), but not rectal (OR 1.49 95% CI 1.02,2.16) cancer.
|
17694420 |
2007 |
|
rs1800795
|
IL6;STEAP1B;IL6-AS1
|
Malignant Neoplasms
|
|
0.040 |
GeneticVariation |
BEFREE |
Having a C allele of the rs1800796 IL6 polymorphisms and the GG genotype of the rs1800795 IL6 polymorphisms was associated with a statistically significantly reduced the risk of colon (OR 0.76 95% CI 0.57, 1.00), but not rectal (OR 1.49 95% CI 1.02,2.16) cancer.
|
17694420 |
2007 |
|
rs1800795
|
IL6;STEAP1B;IL6-AS1
|
Colorectal Carcinoma
|
|
0.030 |
GeneticVariation |
BEFREE |
Data from a multi-center case-control study of colon (N = 1579 cases and N = 1977 controls) and rectal (N = 794 cases and N = 1005 controls) cancer were used to evaluate the association between the rs1800795 and rs1800796 IL6 polymorphisms and CRC.
|
17694420 |
2007 |
|
rs1800796
|
IL6;STEAP1B;IL6-AS1
|
Primary malignant neoplasm
|
|
0.030 |
GeneticVariation |
BEFREE |
Having a C allele of the rs1800796 IL6 polymorphisms and the GG genotype of the rs1800795 IL6 polymorphisms was associated with a statistically significantly reduced the risk of colon (OR 0.76 95% CI 0.57, 1.00), but not rectal (OR 1.49 95% CI 1.02,2.16) cancer.
|
17694420 |
2007 |
|
rs1800796
|
IL6;STEAP1B;IL6-AS1
|
Malignant Neoplasms
|
|
0.030 |
GeneticVariation |
BEFREE |
Having a C allele of the rs1800796 IL6 polymorphisms and the GG genotype of the rs1800795 IL6 polymorphisms was associated with a statistically significantly reduced the risk of colon (OR 0.76 95% CI 0.57, 1.00), but not rectal (OR 1.49 95% CI 1.02,2.16) cancer.
|
17694420 |
2007 |
|
rs1800796
|
IL6;STEAP1B;IL6-AS1
|
Malignant neoplasm of breast
|
|
0.020 |
GeneticVariation |
BEFREE |
IL6 genotype and haplotype significantly modified the association between aspirin and breast cancer, with the greatest effect modification being among women not recently exposed to hormones [P interaction = 0.06 (for non-Hispanic white) and 0.04 (for Hispanic/Native American) and SNP rs1800796 or -572G>C].
|
17416766 |
2007 |
|
rs1800796
|
IL6;STEAP1B;IL6-AS1
|
Colorectal Carcinoma
|
|
0.020 |
GeneticVariation |
BEFREE |
Data from a multi-center case-control study of colon (N = 1579 cases and N = 1977 controls) and rectal (N = 794 cases and N = 1005 controls) cancer were used to evaluate the association between the rs1800795 and rs1800796 IL6 polymorphisms and CRC.
|
17694420 |
2007 |
|
rs1800796
|
IL6;STEAP1B;IL6-AS1
|
Breast Carcinoma
|
|
0.020 |
GeneticVariation |
BEFREE |
IL6 genotype and haplotype significantly modified the association between aspirin and breast cancer, with the greatest effect modification being among women not recently exposed to hormones [P interaction = 0.06 (for non-Hispanic white) and 0.04 (for Hispanic/Native American) and SNP rs1800796 or -572G>C].
|
17416766 |
2007 |
|
rs1800797
|
IL6;STEAP1B;IL6-AS1
|
Malignant neoplasm of breast
|
|
0.020 |
GeneticVariation |
BEFREE |
Among postmenopausal women not recently exposed to hormones, the AG/GG genotypes of rs1800797 (-596A>G) and the GC/CC genotypes of rs1800795 (-174G>C) significantly reduced risk of breast cancer among non-Hispanic white women [odds ratio (OR), 0.69; 95% confidence interval (95% CI), 0.48-1.00 and OR, 0.68; 95% CI, 0.47-0.99, respectively] and Hispanic/Native American women (OR, 0.48; 95% CI, 0.28-0.83 and OR, 0.44; 95% CI, 0.26-0.99, respectively).
|
17416766 |
2007 |
|
rs1800797
|
IL6;STEAP1B;IL6-AS1
|
Breast Carcinoma
|
|
0.020 |
GeneticVariation |
BEFREE |
Among postmenopausal women not recently exposed to hormones, the AG/GG genotypes of rs1800797 (-596A>G) and the GC/CC genotypes of rs1800795 (-174G>C) significantly reduced risk of breast cancer among non-Hispanic white women [odds ratio (OR), 0.69; 95% confidence interval (95% CI), 0.48-1.00 and OR, 0.68; 95% CI, 0.47-0.99, respectively] and Hispanic/Native American women (OR, 0.48; 95% CI, 0.28-0.83 and OR, 0.44; 95% CI, 0.26-0.99, respectively).
|
17416766 |
2007 |
|
rs1800795
|
IL6;STEAP1B;IL6-AS1
|
Glioma
|
|
0.010 |
GeneticVariation |
BEFREE |
The IL4 (rs2243248, -1098T>G) and IL6 (rs1800795, -174G>C) polymorphisms were significantly associated with risk of glioma in the pooled analysis (P trend = 0.006 and 0.04, respectively), although these became attenuated after controlling for the false discovery rate (P trend = 0.07 and 0.22, respectively).
|
17916900 |
2007 |
|
rs747126003
|
IL6;IL6-AS1
|
Head and Neck Carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
The G308A polymorphism of the TNF-alpha gene did not affect levels of inflammatory markers in patients after surgery for head and neck cancer who were treated with early enteral nutrition.
|
17560079 |
2007 |
|
rs747126003
|
IL6;IL6-AS1
|
Malignant Head and Neck Neoplasm
|
|
0.010 |
GeneticVariation |
BEFREE |
The G308A polymorphism of the TNF-alpha gene did not affect levels of inflammatory markers in patients after surgery for head and neck cancer who were treated with early enteral nutrition.
|
17560079 |
2007 |
|
rs1800795
|
IL6;STEAP1B;IL6-AS1
|
Breast Carcinoma
|
|
0.060 |
GeneticVariation |
BEFREE |
Among women without recent hormone exposure, those with a WHR >0.9 and the rs1800795 GG genotype had a greater than threefold increased risk of bre</span>ast cancer (odds ratios (ORs) 3.22, 95% confidence intervals (CIs) 1.27, 817) when compared with women with a WHR <0.8 and the rs1800795 GG genotype (P interaction 0.01).
|
18239642 |
2008 |
|
rs1800795
|
IL6;STEAP1B;IL6-AS1
|
Malignant neoplasm of breast
|
|
0.060 |
GeneticVariation |
BEFREE |
Among women without recent hormone exposure, those with a WHR >0.9 and the rs1800795 GG genotype had a greater than threefold increased risk of bre</span>ast cancer (odds ratios (ORs) 3.22, 95% confidence intervals (CIs) 1.27, 817) when compared with women with a WHR <0.8 and the rs1800795 GG genotype (P interaction 0.01).
|
18239642 |
2008 |
|
rs1800795
|
IL6;STEAP1B;IL6-AS1
|
Degenerative polyarthritis
|
|
0.030 |
GeneticVariation |
BEFREE |
The objective of this study was to investigate the relationship of the IL-6 promoter variants G-597A, G-572C and G-174C (rs1800797, rs1800796 and rs1800795, respectively), which have been shown to affect both the transcription and secretion of IL-6, to symptomatic distal interphalangeal (DIP) osteoarthritis (OA).
|
18257935 |
2008 |